Last reviewed · How we verify

NCT03603821: KILL

Comparison of Self-administered IPSS, Sanitary Staff-supervised IPSS, Medical History and Clinical Parameters

Status unknown Last updated 30 July 2018
What this trial tests

trial testing CLINICAL ASSESMENT in Lower Urinary Tract Symptoms in 150 participants. Status unknown.

Timeline
24 May 2017
Primary endpoint
1 August 2019
1 December 2019

Quick facts

Lead sponsorCorporacion Parc Tauli
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment150
Start date24 May 2017
Primary completion1 August 2019
Estimated completion1 December 2019
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Corporacion Parc Tauli — full company profile →

Who can join

50 and older, male only, with Lower Urinary Tract Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Descriptive prospective study carried out to compare the results obtained by self-administered IPSS (International Prostate Symptom Score), Sanitary staff-supervised IPSS and directed medical interview and its correlation with clinical parameters in the assessment of lower urinary tract symptoms in males.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lower Urinary Tract Symptoms

Currently open trials in the same condition.

Other Corporacion Parc Tauli trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03603821.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing